Collagen III Recombinant Rabbit Monoclonal Antibody [JE60-79]
Usd: 385 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_HA720050_Europe.pdf
- No MSDS Found
Overview
Product Name
Collagen III Recombinant Rabbit Monoclonal Antibody [JE60-79]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human Collagen III 101-400/1,466.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, FC
Target Molecular Weight
Predicted band size: 139 kDa
Positive Control
HeLa cell lysate, A431 cell lysate, SiHa cell lysate, HaCaT cell lysate, NIH/3T3 cell lysate, RAW264.7 cell lysate, C6 cell lysate, PC-12 cell lysate, Mouse heart tissue lysate, Mouse skin tissue lysate, Mouse skeletal muscle tissue lysate, Rat skeletal muscle tissue lysate, Rat skin tissue lysate, SiHa, PC-12, HeLa.
Conjugation
unconjugated
Clone Number
JE60-79
RRID
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:100-1:500
-
FC
-
1:500-1:1,000
Target
Function
Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12. This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome types IV, and with aortic and arterial aneurysms. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene.
Background References
1. Wang R. et. al. Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGFbeta1 axes. Aging (Albany NY). 2019 Nov
2. Kuivaniemi H. et. al. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. Gene. 2019 Jul
Subcellular Location
Extracellular matrix.
Synonyms
Alpha 1 type III collagen antibody
Alpha1 (III) collagen antibody
CO3A1_HUMAN antibody
COL 3A1 antibody
COL3A1 antibody
Collagen alpha 1(III) chain antibody
Collagen alpha-1(III) chain antibody
Collagen III alpha 1 chain precursor antibody
Collagen III alpha 1 polypeptide antibody
Collagen type III alpha 1 (Ehlers Danlos syndrome type IV autosomal dominant) antibody
ExpandAlpha 1 type III collagen antibody
Alpha1 (III) collagen antibody
CO3A1_HUMAN antibody
COL 3A1 antibody
COL3A1 antibody
Collagen alpha 1(III) chain antibody
Collagen alpha-1(III) chain antibody
Collagen III alpha 1 chain precursor antibody
Collagen III alpha 1 polypeptide antibody
Collagen type III alpha 1 (Ehlers Danlos syndrome type IV autosomal dominant) antibody
Collagen type III alpha 1 antibody
Collagen type III alpha 1 chain antibody
Collagen type III alpha antibody
Collagen, fetal antibody
EDS4A antibody
Ehlers Danlos syndrome type IV, autosomal dominant antibody
Fetal collagen antibody
Type III collagen antibody
CollapseImages
-
Western blot analysis of Collagen III on different lysates with Rabbit anti-Collagen III antibody (HA720050) at 1/1,000 dilution.
Lane 1: HeLa cell lysate (20 µg/Lane)
Lane 2: A431 cell lysate (20 µg/Lane)
Lane 3: SiHa cell lysate (20 µg/Lane)
Lane 4: HaCaT cell lysate (20 µg/Lane)
Lane 5: NIH/3T3 cell lysate (20 µg/Lane)
Lane 6: RAW264.7 cell lysate (20 µg/Lane)
Lane 7: C6 cell lysate (20 µg/Lane)
Lane 8: PC-12 cell lysate (20 µg/Lane)
Lane 9: Mouse heart tissue lysate (20 µg/Lane)
Lane 10: Mouse skin tissue lysate (20 µg/Lane)
Predicted band size: 139 kDa
Observed band size: 150 kDa
Exposure time: 2 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA720050) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of Collagen III on different lysates with Rabbit anti-Collagen III antibody (HA720050) at 1/1,000 dilution.
Lane 1: Mouse heart tissue lysate (20 µg/Lane)
Lane 2: Mouse skeletal muscle tissue lysate (20 µg/Lane)
Lane 3: Rat skeletal muscle tissue lysate (20 µg/Lane)
Lane 4: Rat skin tissue lysate (20 µg/Lane)
Predicted band size: 139 kDa
Observed band size: 150 kDa
Exposure time: 2 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA720050) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of SiHa cells labeling Collagen III with Rabbit anti-Collagen III antibody (HA720050) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Collagen III antibody (HA720050) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of PC-12 cells labeling Collagen III with Rabbit anti-Collagen III antibody (HA720050) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Collagen III antibody (HA720050) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HeLa cells labeling Collagen III.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA720050, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Mesoporous bioactive glass–recombinant collagen III nanocomposite capsule promotes skin wound healing via adaptive immune modulation
Journal: Regenerative Biomaterials
DOI: 10.1093/rb/rbag092
IF: 8.7
Application: WB
Reactivity: Mouse
Publish date: 2026 May
-
A Targeted Nanozyme for STING Activation Improves BiTEs Therapy Outcomes in Colorectal Cancer
Journal: Small
DOI: 10.1002/smll.202514390
IF: 12.1
Application: WB,IP,IHC-P
Reactivity: human,mouse ,rat
Publish date: 2026 Mar
-
Apoptotic Vesicle Membrane-Mediated Targeted Endothelial Mitochondrial Transplantation-Clearance Therapy for Diabetic Wound Healing
Journal: Research
DOI: 10.34133/research.1042
IF: 10.7
Application: IF-tissue
Reactivity: Rat
Publish date: 2026 Jan
-
Immunotherapy-induced sialadenitis: sjögren’s syndrome or a new sialadenitis
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2026.1755419
IF: 5.9
Application: WB
Reactivity: Human,Mouse
Publish date: 2026 Feb
-
Serpine1 Regulates the Enhanced Inhibitory Effect of CHIR99021 Combined with Fibroblast Growth Factor 2 on Myocardial Fibrosis After Myocardial Infarction in Mice
Journal: International Journal Of Molecular Sciences
DOI: 10.3390/ijms27041627
IF: 4.9
Application: IF-cell,WB
Reactivity: Rat
Publish date: 2026 Feb
-
Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF-κB-mediated inflammation and alleviate atherosclerosis
Journal: British Journal Of Pharmacology
DOI: 10.1111/bph.70475
IF: 7.7
Application: WB,IF-Cell
Reactivity: Human
Publish date: 2026 Apr
-
Ailanthone ameliorates CCl4-induced liver fibrosis by targeting PKM2-mediated macrophage M1 polarization and glycolytic reprogramming
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2026.116640
IF: 4.7
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Apr
-
Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis
Journal: Journal of Biomaterials Science, Polymer Edition
DOI: 10.1016/j.phymed.2026.158141
IF: 8.3
Application: IHC,WB
Reactivity: Mouse,Human,Rat
Publish date: 2026 Apr
-
Chrysin inhibits hypertrophic scar formation through TGF-β/Smad signaling pathways
Journal: Journal Of Molecular Histology
DOI: 10.1007/s10735-025-10576-3
IF: 2.2
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
L-cysteine rescues radiation induced ferroptosis and boosts wound healing through fibroblasts proliferation and migration
Journal: Biochemical And Biophysical Research Communications
DOI: 10.1016/j.bbrc.2025.152599
IF: 2.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115066
IF: 4.7
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
JOSD2 inhibits angiotensin II-induced vascular remodeling by deubiquitinating and stabilizing SMAD7
Journal: ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/s41401-024-01437-y
IF: 8.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
JOSD2 inhibits angiotensin II-induced vascular remodeling by deubiquitinating and stabilizing SMAD7
Journal: Acta Pharmacologica Sinica
DOI:
IF: 6.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
tiRNA-Gly-GCC-002 promotes epithelial-mesenchymal transition and fibrosis in lupus nephritis via FKBP5-mediated activation of Smad
Journal: British Journal Of Pharmacology
DOI: 10.1111/bph.17364
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway
Journal: Biogerontology
DOI:
IF: 4.5
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
Anshen Shumai Decoction inhibits post-infarction inflammation and myocardial remodeling through suppression of the p38 MAPK/c-FOS/EGR1 pathway
Journal: Journal Of Molecular Histology
DOI:
IF: 3.2
Application: WB
Reactivity: Rat
Publish date: 2024 Jun
-
MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome
Journal: Public Library Of Science One
DOI:
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
PEEP application during mechanical ventilation contributes to fibrosis in the diaphragm
Journal: Respiratory Research
DOI:
IF: 7.162
Application: IF-tissue,WB
Reactivity: Rabbit
Publish date: 2023 Feb
-
Icariin alleviates osteoarthritis through PI3K/Akt/mTOR/ULK1 signaling pathway
Journal: European Journal Of Medical Research
DOI:
IF: 4.981
Application: WB
Reactivity: Human
Publish date: 2022 Oct
-
Intra-bone marrow injection of magnesium isoglyrrhizinate inhibits inflammation and delays osteoarthritis progression through the NF-κB pathway
Journal: Journal Of Orthopaedic Surgery And Research
DOI:
IF: 2.677
Application: WB
Reactivity: Rabbit
Publish date: 2022 Aug